2 comments By Julie Grisham, MS, Science Writer/Editor | Thursday, December 11, 2014 An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.
Add a Comment By Maureen Salamon, BA, Freelance Writer | Friday, October 3, 2014 For people undergoing bone marrow or stem cell transplants, being isolated from friends, family, and everyday life can make recovery more difficult. read more
1 comment By Jim Stallard, MA, Writer/Editor | Thursday, September 25, 2014 Transplant patients at Memorial Sloan Kettering gave support to bone marrow donation efforts with their own “walk” inside the hospital. read more
Add a Comment By Maureen Salamon, BA, Freelance Writer | Monday, May 19, 2014 Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.
Add a Comment By Media Staff | Thursday, April 10, 2014 Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research. read more
8 comments By Julie Grisham, MS, Science Writer/Editor | Thursday, February 20, 2014 A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment. read more
Add a Comment By Julie Grisham, MS, Science Writer/Editor | Monday, December 23, 2013 Memorial Sloan-Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine. read more